LINGO4 coordinates ILC3-intrinsic IL-22 production and microbiota-mediated ILC3 homeostasis
Authors:
- José L. FachiJFJosé L. Fachi
- Tihana TrsanTTTihana Trsan
- Cristiane SéccaCSCristiane Sécca
- Sarah de OliveiraSOSarah de Oliveira
- Vinícius R. RodovalhoVRVinícius R. Rodovalho
- Patrick Fernandes RodriguesPRPatrick Fernandes Rodrigues
- Wandy L. BeattyWBWandy L. Beatty
- Raki SudanRSRaki Sudan
- Shitong WuSWShitong Wu
- Bishan BhattaraiBBBishan Bhattarai
- Santosh K. PandaSPSantosh K. Panda
- Marina CellaMCMarina Cella
- 28 April 2026
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (6)
Abstract
LINGO4 is a leucine-rich repeat and immunoglobulin-like domain-containing transmembrane protein encoded immediately adjacent to Rorc, the gene for RORγt, raising the possibility that it contributes to the biology of RORγt+ lymphocytes. However, its impact on these cells and resistance to enteric infections has remained unknown. Here, we identify LINGO4 as a critical regulator of group 3 innate lymphoid cells (ILC3s). Lingo4−/− ILC3s exhibit a profound, cell-intrinsic defect in IL-22 production linked to impaired STAT3 activation, mitochondrial dysfunction, elevated ROS, and increased apoptosis. In vivo, Lingo4 deficiency also drives a dysbiotic gut microbiota, resulting in an additional, microbiota-dependent loss of ILC3s. These combined defects increase susceptibility to Clostridioides difficile and Citrobacter rodentium, whereas IL-22 reduction in Lingo4−/− mice confers protection against Salmonellatyphimurium. Immunoprecipitation of tagged LINGO4 reveals interaction networks enriched in mitochondrial pathways, providing mechanistic insight into its role in ILC3 metabolic fitness and intestinal immunity.Keywords
Funding Information
- National Institutes of Health (S10 OD032131)
- National Institutes of Health (WLC6313040077)
- National Institutes of Health (R01DK126969)
- National Institutes of Health (R01DK132327)
- National Cancer Institute (#P30 CA91842)
- Institute of Clinical and Translational Sciences
- Clinical and Translational Science Award (UL1TR000448)
- National Center for Research Resources
- National Science Foundation (No. DBI-1827534)
- Pew Charitable Trusts (00035299)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2017/06577-9)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2023/00393-4)
This publication has 72 references indexed in Scilit:
- The metabolic sensor LKB1 regulates ILC3 homeostasis and mitochondrial functionCell Reports, 2025
- Fiber- and acetate-mediated modulation of MHC-II expression on intestinal epithelium protects from Clostridioides difficile infectionCell Host & Microbe, 2025
- Murine Models of Salmonella InfectionCurrent Protocols, 2023
- Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial DysbiosisImmunity, 2018
- Innate Lymphoid Cells: 10 Years OnCell, 2018
- The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the MicrobiomeCell, 2016
- Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile InfectionCell Host & Microbe, 2015
- The Cytokine IL-22 Promotes Pathogen Colonization by Suppressing Related Commensal BacteriaImmunity, 2014
- Induction of Innate Lymphoid Cell-Derived Interleukin-22 by the Transcription Factor STAT3 Mediates Protection against Intestinal InfectionImmunity, 2014
- Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune DefenseImmunity, 2008